Insulet Corporation (NASDAQ: PODD) is a medical device company that develops and manufactures the Omnipod product platform, a tubeless, wearable insulin delivery system providing continuous insulin delivery for people with diabetes. The company also adapts its Pod technology for delivery of non-insulin subcutaneous drugs across other therapeutic areas, with products available in 26 countries worldwide.